Vanda Pharmaceuticals (VNDA, $4.77) was one of top quarterly gainers, jumping +2 to $4.77 per share. A.I.dvisor analyzed 915 stocks in the Biotechnology Industry over the last three months, and discovered that of them (4) charted an Uptrend while of them (5) trended down.